GGrantIndex
← Search

Purchase of pharmaceutical agents for NIAID clinical trials

$194,416Y01FY2019AINIH

National Institute Of Allergy And Infectious Diseases

Investigators

Abstract

DLA Prime Vendor Program, is an intra-agency agreement that allows DAIT/ NIAID to purchase pharmaceutical agents with streamlined government pricing and negotiations.

View original record on NIH RePORTER →